| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
39,681 |
29,242 |
$1.35M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
23,807 |
16,978 |
$623K |
| 95923 |
|
1,016 |
731 |
$41K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,649 |
3,307 |
$38K |
| 80305 |
|
11,324 |
8,412 |
$37K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
888 |
677 |
$37K |
| 93922 |
|
869 |
631 |
$21K |
| 94729 |
|
898 |
741 |
$20K |
| 99406 |
|
3,009 |
2,160 |
$20K |
| 95921 |
|
650 |
480 |
$18K |
| 94727 |
|
901 |
744 |
$16K |
| 99441 |
|
5,000 |
3,474 |
$13K |
| 94010 |
|
544 |
445 |
$8K |
| 1160F |
|
38,523 |
27,380 |
$8K |
| 3078F |
|
19,081 |
13,883 |
$7K |
| 3074F |
|
23,367 |
16,930 |
$7K |
| 3079F |
|
11,567 |
9,076 |
$6K |
| 20553 |
|
322 |
245 |
$6K |
| 1159F |
|
26,840 |
19,257 |
$6K |
| 1126F |
|
19,530 |
13,966 |
$6K |
| 3008F |
|
31,690 |
22,519 |
$6K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,713 |
1,173 |
$6K |
| 94375 |
|
308 |
256 |
$5K |
| 1125F |
|
12,972 |
9,708 |
$4K |
| 99490 |
Ccm add 20min |
1,814 |
1,487 |
$4K |
| 95957 |
|
64 |
48 |
$3K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,527 |
1,897 |
$3K |
| 3077F |
|
3,209 |
2,600 |
$3K |
| 99306 |
Prolong nursin fac eval 15m |
92 |
70 |
$3K |
| 95816 |
|
64 |
48 |
$3K |
| 3075F |
|
5,688 |
4,571 |
$2K |
| 93000 |
|
270 |
228 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
103 |
78 |
$2K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
32 |
29 |
$2K |
| 3080F |
|
1,546 |
1,211 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
275 |
205 |
$2K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
17 |
16 |
$2K |
| 95250 |
|
73 |
60 |
$1K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
26 |
25 |
$1K |
| 90686 |
|
174 |
117 |
$1K |
| 90674 |
|
121 |
96 |
$1K |
| 20610 |
|
58 |
31 |
$1K |
| 93925 |
|
16 |
14 |
$893.14 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,890 |
1,346 |
$743.02 |
| 99215 |
Prolong outpt/office vis |
25 |
21 |
$728.46 |
| 20552 |
|
30 |
25 |
$659.46 |
| 90688 |
|
96 |
61 |
$596.41 |
| 93880 |
|
12 |
12 |
$568.55 |
| 95251 |
|
58 |
56 |
$563.69 |
| 81002 |
|
586 |
436 |
$515.58 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
172 |
140 |
$490.10 |
| 96127 |
|
213 |
139 |
$470.22 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
30 |
17 |
$393.36 |
| 92546 |
|
15 |
12 |
$389.52 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
16 |
14 |
$375.28 |
| 36415 |
Collection of venous blood by venipuncture |
525 |
303 |
$338.16 |
| 96138 |
|
64 |
48 |
$331.10 |
| 96139 |
|
28 |
27 |
$307.54 |
| 96125 |
|
71 |
39 |
$219.39 |
| 95943 |
|
51 |
40 |
$218.01 |
| 93040 |
|
64 |
48 |
$183.70 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
66 |
49 |
$134.06 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
16 |
12 |
$111.24 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
80 |
54 |
$100.20 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
696 |
280 |
$69.31 |
| 90756 |
|
47 |
39 |
$51.21 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
84 |
65 |
$49.07 |
| 92547 |
|
15 |
12 |
$47.07 |
| G0008 |
Administration of influenza virus vaccine |
119 |
88 |
$30.84 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
37 |
27 |
$12.15 |
| J3490 |
Unclassified drugs |
145 |
111 |
$4.99 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
725 |
534 |
$4.99 |
| J7509 |
Methylprednisolone oral, per 4 mg |
45 |
32 |
$4.80 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
1,904 |
1,382 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
14,052 |
9,588 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
7,194 |
5,340 |
$0.00 |
| G8731 |
Pain assessment using a standardized tool is documented as negative, no follow-up plan required |
2,542 |
1,643 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
9,102 |
6,710 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
3,432 |
2,485 |
$0.00 |
| G8477 |
Most recent blood pressure has a systolic measurement of >= 140 mmhg and/or a diastolic measurement of >= 90 mmhg |
169 |
134 |
$0.00 |
| G8476 |
Most recent blood pressure has a systolic measurement of < 140 mmhg and a diastolic measurement of < 90 mmhg |
274 |
203 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
53 |
48 |
$0.00 |
| 99499 |
|
173 |
166 |
$0.00 |
| G0402 |
Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment |
71 |
39 |
$0.00 |
| G8421 |
Bmi not documented and no reason is given |
89 |
72 |
$0.00 |
| 1158F |
|
155 |
69 |
$0.00 |
| G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
147 |
60 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
7,304 |
5,470 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
9,849 |
7,283 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
1,275 |
903 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
1,208 |
823 |
$0.00 |
| G8422 |
Bmi not documented, documentation the patient is not eligible for bmi calculation |
1,015 |
753 |
$0.00 |
| G8473 |
Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescribed |
30 |
21 |
$0.00 |
| 3044F |
|
58 |
41 |
$0.00 |
| 4010F |
|
30 |
21 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
71 |
46 |
$0.00 |
| 1170F |
|
98 |
46 |
$0.00 |